These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 7708691)

  • 21. Point mutations and overexpression of Ron induce transformation, tumor formation, and metastasis.
    Peace BE; Hughes MJ; Degen SJ; Waltz SE
    Oncogene; 2001 Sep; 20(43):6142-51. PubMed ID: 11593422
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Interaction between Gab1 and the c-Met receptor tyrosine kinase is responsible for epithelial morphogenesis.
    Weidner KM; Di Cesare S; Sachs M; Brinkmann V; Behrens J; Birchmeier W
    Nature; 1996 Nov; 384(6605):173-6. PubMed ID: 8906793
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identification of mutations in the coding sequence of the proto-oncogene c-kit in a human mast cell leukemia cell line causing ligand-independent activation of c-kit product.
    Furitsu T; Tsujimura T; Tono T; Ikeda H; Kitayama H; Koshimizu U; Sugahara H; Butterfield JH; Ashman LK; Kanayama Y
    J Clin Invest; 1993 Oct; 92(4):1736-44. PubMed ID: 7691885
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A juxtamembrane autophosphorylation site in the Eph family receptor tyrosine kinase, Sek, mediates high affinity interaction with p59fyn.
    Ellis C; Kasmi F; Ganju P; Walls E; Panayotou G; Reith AD
    Oncogene; 1996 Apr; 12(8):1727-36. PubMed ID: 8622893
    [TBL] [Abstract][Full Text] [Related]  

  • 25. c-MET mutational analysis in small cell lung cancer: novel juxtamembrane domain mutations regulating cytoskeletal functions.
    Ma PC; Kijima T; Maulik G; Fox EA; Sattler M; Griffin JD; Johnson BE; Salgia R
    Cancer Res; 2003 Oct; 63(19):6272-81. PubMed ID: 14559814
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Membrane targeting of Grb2-associated binder-1 (Gab1) scaffolding protein through Src myristoylation sequence substitutes for Gab1 pleckstrin homology domain and switches an epidermal growth factor response to an invasive morphogenic program.
    Maroun CR; Naujokas MA; Park M
    Mol Biol Cell; 2003 Apr; 14(4):1691-708. PubMed ID: 12686619
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Differential requirement of Tyr1062 multidocking site by RET isoforms to promote neural cell scattering and epithelial cell branching.
    Degl'Innocenti D; Arighi E; Popsueva A; Sangregorio R; Alberti L; Rizzetti MG; Ferrario C; Sariola H; Pierotti MA; Borrello MG
    Oncogene; 2004 Sep; 23(44):7297-309. PubMed ID: 15326489
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficient cell transformation by the Tpr-Met oncoprotein is dependent upon tyrosine 489 in the carboxy-terminus.
    Fixman ED; Naujokas MA; Rodrigues GA; Moran MF; Park M
    Oncogene; 1995 Jan; 10(2):237-49. PubMed ID: 7838524
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Scatter factor and the c-met receptor: a paradigm for mesenchymal/epithelial interaction.
    Rosen EM; Nigam SK; Goldberg ID
    J Cell Biol; 1994 Dec; 127(6 Pt 2):1783-7. PubMed ID: 7806559
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Modulation of hepatocyte growth factor and c-met in the rat mammary gland during pregnancy, lactation, and involution.
    Pepper MS; Soriano JV; Menoud PA; Sappino AP; Orci L; Montesano R
    Exp Cell Res; 1995 Jul; 219(1):204-10. PubMed ID: 7628535
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tyrosine kinase inhibitor STI571 enhances thyroid cancer cell motile response to Hepatocyte Growth Factor.
    Frasca F; Vigneri P; Vella V; Vigneri R; Wang JY
    Oncogene; 2001 Jun; 20(29):3845-56. PubMed ID: 11439348
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification of tyrosine 489 in the carboxy terminus of the Tpr-Met oncoprotein as a major site of autophosphorylation.
    Kamikura DM; Naujokas MA; Park M
    Biochemistry; 1996 Jan; 35(3):1010-7. PubMed ID: 8547236
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hepatocyte growth factor/scatter factor (HGF/SF), the c-met receptor and the behaviour of epithelial cells.
    Gherardi E; Sharpe M; Lane K; Sirulnik A; Stoker M
    Symp Soc Exp Biol; 1993; 47():163-81. PubMed ID: 8165564
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Structure, biosynthesis and biochemical properties of the HGF receptor in normal and malignant cells.
    Comoglio PM
    EXS; 1993; 65():131-65. PubMed ID: 8380735
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hepatocyte growth factor/scatter factor activates the ETS1 transcription factor by a RAS-RAF-MEK-ERK signaling pathway.
    Paumelle R; Tulasne D; Kherrouche Z; Plaza S; Leroy C; Reveneau S; Vandenbunder B; Fafeur V
    Oncogene; 2002 Apr; 21(15):2309-19. PubMed ID: 11948414
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Modulation of HGF-induced tubulogenesis and branching by multiple phosphorylation mechanisms.
    Santos OF; Moura LA; Rosen EM; Nigam SK
    Dev Biol; 1993 Oct; 159(2):535-48. PubMed ID: 8405677
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The hepatocyte growth factor and its receptor.
    Galimi F; Brizzi MF; Comoglio PM
    Stem Cells; 1993 Jul; 11 Suppl 2():22-30. PubMed ID: 8401259
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dissecting the thrombopoietin receptor: functional elements of the Mpl cytoplasmic domain.
    Drachman JG; Kaushansky K
    Proc Natl Acad Sci U S A; 1997 Mar; 94(6):2350-5. PubMed ID: 9122198
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hepatocyte growth factor/scatter factor effects on epithelia. Regulation of intercellular junctions in transformed and nontransformed cell lines, basolateral polarization of c-met receptor in transformed and natural intestinal epithelia, and induction of rapid wound repair in a transformed model epithelium.
    Nusrat A; Parkos CA; Bacarra AE; Godowski PJ; Delp-Archer C; Rosen EM; Madara JL
    J Clin Invest; 1994 May; 93(5):2056-65. PubMed ID: 8182137
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Activation of the hepatocyte growth factor (HGF)-Met system in papillary thyroid cancer: biological effects of HGF in thyroid cancer cells depend on Met expression levels.
    Mineo R; Costantino A; Frasca F; Sciacca L; Russo S; Vigneri R; Belfiore A
    Endocrinology; 2004 Sep; 145(9):4355-65. PubMed ID: 15192042
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.